Clinical Trial Update: Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether valsartan reduces proteinuria in patients with hypertension and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Proteinuria
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIOVAN (valsartan)

Snippet

Sponsor: Novartis | Conditions: PROTEINURIA, Hypertension | Phase 4 | Status: COMPLETED